CHST4 associates with high-abundance immune infiltration in hormone receptor–positive breast cancer
Journal of Leukocyte Biology · 2024
DOI: 10.1093/jleuko/qiae190 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Yansong Liu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Sulfotransferases, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Hormone receptor–positive breast cancer (HR+ BRCA) with high-risk factors such as lymph node metastasis has a relatively poor prognosis. However, the biological basis of tumor cell migration is still poorly understood, especially as some of the metastatic events occur at an early stage. Here, we identified that CHST4 (carbohydrate sulfotransferase 4), which has an important role in lymphocyte homing, was abnormally downregulated in HR+ BRCA and associated with lymph node metastasis. By enrichment analysis and immune infiltration evaluation, we predicted the potential ability of CHST4 to enhance immune cell infiltration. Then, immunohistochemical staining further demonstrated the contribution of CHST4 to the infiltration abundance of CD8+ T cells and CD4+ T cells in HR+ BRCA. Immunohistochemical staining of MECA-79 further identified the correlation between CHST4 and sulfated peripheral node addressin. Finally, we demonstrated that CHST4 was connected to increased tumor-immune cell communication by analyzing single-cell sequencing data. In summary, our study provided novel insights into the regulation of HR+ BRCA immune infiltration by CHST4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China.
- Department of General Surgery, Daqing Oilfield General Hospital, Daqing 163316, China.
ORCID-Profile: Baoliang Guo
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, Y., Hu, A., Shakila, S. S., Cheng, W., Wang, T., Zhang, J., Yu, T., Duan, Y., Feng, J., Ding, Y., Zhang, H., Li, Y., Li, M., Rong, Z., Shang, Y., Fang, Z., Liu, J., Kong, F., & Guo, B. (2024). CHST4 associates with high-abundance immune infiltration in hormone receptor–positive breast cancer. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae190
Vancouver
Liu Y, Hu A, Shakila SS, Cheng W, Wang T, Zhang J, et al. CHST4 associates with high-abundance immune infiltration in hormone receptor–positive breast cancer. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae190
BibTeX
@article{Liu2024,
author = {Liu, Yansong and Hu, Anbang and Shakila, Suborna S and Cheng, Weilun and Wang, Ting and Zhang, Jiarui and Yu, Tianshui and Duan, Yunqiang and Feng, Jianyuan and Ding, Yu and Zhang, Hanyu and Li, Yanling and Li, Mingcui and Rong, Zhiyuan and Shang, Yuhang and Fang, Zhengbo and Liu, Jiangwei and Kong, Fanjing and Guo, Baoliang},
title = {CHST4 associates with high-abundance immune infiltration in hormone receptor–positive breast cancer},
journal = {Journal of Leukocyte Biology},
year = {2024},
doi = {10.1093/jleuko/qiae190}
}
EUVIMED